BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 17681179)

  • 1. Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
    Li P; Schulz S; Bombonati A; Palazzo JP; Hyslop TM; Xu Y; Baran AA; Siracusa LD; Pitari GM; Waldman SA
    Gastroenterology; 2007 Aug; 133(2):599-607. PubMed ID: 17681179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex modulates intestinal transformation by the tumor-suppressor GCC.
    Li P; Schulz S; Pitari GM; Waldman SA
    Clin Transl Sci; 2008 Sep; 1(2):146-50. PubMed ID: 20443837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.
    Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP
    Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of guanylyl cyclase C, the receptor for Escherichia coli heat-stable enterotoxin, results in reduced polyp formation and increased apoptosis in the multiple intestinal neoplasia (Min) mouse model.
    Mann EA; Steinbrecher KA; Stroup C; Witte DP; Cohen MB; Giannella RA
    Int J Cancer; 2005 Sep; 116(4):500-5. PubMed ID: 15825168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can colorectal cancer be prevented or treated by oral hormone replacement therapy?
    Li P; Lin JE; Schulz S; Pitari GM; Waldman SA
    Curr Mol Pharmacol; 2009 Nov; 2(3):285-92. PubMed ID: 20021465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
    Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
    Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis.
    Kress E; Skah S; Sirakov M; Nadjar J; Gadot N; Scoazec JY; Samarut J; Plateroti M
    Gastroenterology; 2010 May; 138(5):1863-74. PubMed ID: 20114049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.
    Shailubhai K; Yu HH; Karunanandaa K; Wang JY; Eber SL; Wang Y; Joo NS; Kim HD; Miedema BW; Abbas SZ; Boddupalli SS; Currie MG; Forte LR
    Cancer Res; 2000 Sep; 60(18):5151-7. PubMed ID: 11016642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corruption of homeostatic mechanisms in the guanylyl cyclase C signaling pathway underlying colorectal tumorigenesis.
    Li P; Waldman SA
    Cancer Biol Ther; 2010 Aug; 10(3):211-8. PubMed ID: 20592492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88.
    Rakoff-Nahoum S; Medzhitov R
    Science; 2007 Jul; 317(5834):124-7. PubMed ID: 17615359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice.
    Musteanu M; Blaas L; Mair M; Schlederer M; Bilban M; Tauber S; Esterbauer H; Mueller M; Casanova E; Kenner L; Poli V; Eferl R
    Gastroenterology; 2010 Mar; 138(3):1003-11.e1-5. PubMed ID: 19962983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
    Li Q; Ishikawa TO; Oshima M; Taketo MM
    Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer is a paracrine deficiency syndrome amenable to oral hormone replacement therapy.
    Li P; Lin JE; Snook AE; Gibbons AV; Zuzga DS; Schulz S; Pitari GM; Waldman SA
    Clin Transl Sci; 2008 Sep; 1(2):163-7. PubMed ID: 19727435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
    Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesis.
    Yerushalmi HF; Besselsen DG; Ignatenko NA; Blohm-Mangone KA; Padilla-Torres JL; Stringer DE; Cui H; Holubec H; Payne CM; Gerner EW
    Mol Carcinog; 2006 Feb; 45(2):93-105. PubMed ID: 16329147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The paracrine hormone hypothesis of colorectal cancer.
    Pitari GM; Li P; Lin JE; Zuzga D; Gibbons AV; Snook AE; Schulz S; Waldman SA
    Clin Pharmacol Ther; 2007 Oct; 82(4):441-7. PubMed ID: 17687268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clock genes and cancer.
    Wood PA; Yang X; Hrushesky WJ
    Integr Cancer Ther; 2009 Dec; 8(4):303-8. PubMed ID: 20042409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling.
    Samuel MS; Suzuki H; Buchert M; Putoczki TL; Tebbutt NC; Lundgren-May T; Christou A; Inglese M; Toyota M; Heath JK; Ward RL; Waring PM; Ernst M
    Gastroenterology; 2009 Sep; 137(3):902-13, 913.e1-11. PubMed ID: 19454286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E. coli heat-stable enterotoxin and guanylyl cyclase C: new functions and unsuspected actions.
    Giannella RA; Mann EA
    Trans Am Clin Climatol Assoc; 2003; 114():67-85; discussion 85-6. PubMed ID: 12813912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyethylene glycol inhibits intestinal neoplasia and induces epithelial apoptosis in Apc(min) mice.
    Roy HK; Gulizia J; DiBaise JK; Karolski WJ; Ansari S; Madugula M; Hart J; Bissonnette M; Wali RK
    Cancer Lett; 2004 Nov; 215(1):35-42. PubMed ID: 15374630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.